Skip to main content
Top
Published in: Endocrine Pathology 3/2018

Open Access 01-09-2018

Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations

Authors: George Papaxoinis, Angela Lamarca, Anne Marie Quinn, Wasat Mansoor, Daisuke Nonaka

Published in: Endocrine Pathology | Issue 3/2018

Login to get access

Abstract

Pulmonary carcinoid tumors occur in both central and peripheral locations, and some differences in clinico-pathological features have long been observed. We investigated a large number of resected carcinoid tumors with the aim to further define the characteristics of tumors from both locations. One hundred sixty-six resected carcinoid tumors of the lung were analyzed for a variety of clinical and pathologic features, including histology subtype, mitotic rate, Ki67 index, necrosis, invasive pattern, architectural pattern, cell morphology, sustentacular cells, neuroendocrine hyperplasia, and orthopedia homeobox protein (OTP) and TTF-1 immunohistochemical expressions. Unsupervised hierarchical cluster analysis suggested three clusters as the best solution using TTF-1 and OTP expression: TTF-1-positive and OTP-positive tumors as cluster 1, TTF-1-positive but OTP-negative as cluster 2, and TTF-1-negative and OTP-negative as cluster 3. Cluster 1 was characterized by peripheral location, presence of spindle cell component, presence of sustentacular cells, female predominance, and strong association with neuroendocrine hyperplasia. Cluster 2 was characterized by central location, polygonal cell morphology, acinar growth pattern in a subset of tumors, and only rare association with neuroendocrine hyperplasia. Cluster 3 consisted of more aggressive tumors with more heterogeneous pathologic features. Tumors showed polygonal cell morphology and acinar growth pattern. Occurrence of neuroendocrine hyperplasia was exceptional. Our study confirmed distinct characteristics of central and peripheral type carcinoid. An important difference was a strong association of the peripheral tumor with neuroendocrine hyperplasia while such an association in central tumors was negligible. The tumor location might be relevant for pathobiology of lung carcinoid tumors.
Literature
1.
go back to reference Travis WD, Brambilla E, Burke AP, Marx X, Nicholson AP (2015) Neuroendocrine tumours. In: Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H (eds). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IARC, Lyon, pp 63–79 Travis WD, Brambilla E, Burke AP, Marx X, Nicholson AP (2015) Neuroendocrine tumours. In: Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H (eds). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IARC, Lyon, pp 63–79
2.
go back to reference Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G (2014) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 21:1–16.CrossRefPubMed Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G (2014) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 21:1–16.CrossRefPubMed
3.
go back to reference Travis WD, Giroux DJ, Chansky K, Crowley J, Asamura H, Brambilla E, Jett J, Kennedy C, Rami-Porta R, Rusch VW, Goldstraw P (2008) The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 3:1213–1223.CrossRefPubMed Travis WD, Giroux DJ, Chansky K, Crowley J, Asamura H, Brambilla E, Jett J, Kennedy C, Rami-Porta R, Rusch VW, Goldstraw P (2008) The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 3:1213–1223.CrossRefPubMed
4.
go back to reference Swarts DR, Claessen SM, Jonkers YM, van Suylen RJ, Dingemans AM, de Herder WW, de Krijger RR, Smit EF, Thunnissen FB, Seldenrijk CA, Vink A, Perren A, Ramaekers FC, Speel EJ (2011) Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome. Am J Pathol 179:1129–1137.CrossRefPubMedPubMedCentral Swarts DR, Claessen SM, Jonkers YM, van Suylen RJ, Dingemans AM, de Herder WW, de Krijger RR, Smit EF, Thunnissen FB, Seldenrijk CA, Vink A, Perren A, Ramaekers FC, Speel EJ (2011) Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome. Am J Pathol 179:1129–1137.CrossRefPubMedPubMedCentral
5.
go back to reference Swarts DR, Henfling ME, Van Neste L, van Suylen RJ, Dingemans AM, Dinjens WN, Haesevoets A, Rudelius M, Thunnissen E, Volante M, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ (2013) CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Clin Cancer Res 19:2197–2207.CrossRefPubMed Swarts DR, Henfling ME, Van Neste L, van Suylen RJ, Dingemans AM, Dinjens WN, Haesevoets A, Rudelius M, Thunnissen E, Volante M, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ (2013) CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Clin Cancer Res 19:2197–2207.CrossRefPubMed
6.
go back to reference Coppola D, Clarke M, Landreneau R, Weyant RJ, Cooper D, Yousem SA: Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung (1996) Mod Pathol 9:484–490.PubMed Coppola D, Clarke M, Landreneau R, Weyant RJ, Cooper D, Yousem SA: Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung (1996) Mod Pathol 9:484–490.PubMed
7.
go back to reference Bonikos DS, Bensch KG, Jamplis RW (1976) Peripheral pulmonary carcinoid tumors. Cancer 37:1977–1998.CrossRefPubMed Bonikos DS, Bensch KG, Jamplis RW (1976) Peripheral pulmonary carcinoid tumors. Cancer 37:1977–1998.CrossRefPubMed
8.
go back to reference Solcia E, Arnold R, Capella C, Klimstra DS, Knomminoth P, Rindi G (2010) Neuroendocrine neoplasms of the stomach. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of tumours of the digestive system. IARC Press, Lyon, pp 64–68 Solcia E, Arnold R, Capella C, Klimstra DS, Knomminoth P, Rindi G (2010) Neuroendocrine neoplasms of the stomach. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of tumours of the digestive system. IARC Press, Lyon, pp 64–68
9.
go back to reference Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401.CrossRefPubMedPubMedCentral Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401.CrossRefPubMedPubMedCentral
10.
go back to reference Wirtschafter E, Walts AE, Liu ST, Marchevsky AM (2015) Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence. Lung 193:659–667.CrossRefPubMed Wirtschafter E, Walts AE, Liu ST, Marchevsky AM (2015) Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence. Lung 193:659–667.CrossRefPubMed
11.
go back to reference Marchevsky AM, Wirtschafter E, Walts AE (2015) The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Hum Pathol 46:176–181.CrossRefPubMed Marchevsky AM, Wirtschafter E, Walts AE (2015) The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Hum Pathol 46:176–181.CrossRefPubMed
12.
go back to reference Colby TV, Koss MN, Travis WD (1994) Tumors of the lower respiratory tract. AFIP, Washington DC Colby TV, Koss MN, Travis WD (1994) Tumors of the lower respiratory tract. AFIP, Washington DC
13.
go back to reference Rosai J (1989) Respiratory tract. In: Rosai J (ed) Ackerman’s surgical pathology. Mosby company, St Louis, C.V., pp 229–343 Rosai J (1989) Respiratory tract. In: Rosai J (ed) Ackerman’s surgical pathology. Mosby company, St Louis, C.V., pp 229–343
14.
go back to reference Carter DL, Eggleston J (1979) Tumors of the respiratory tract. AFIP, Washington DC Carter DL, Eggleston J (1979) Tumors of the respiratory tract. AFIP, Washington DC
15.
go back to reference Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, Weidner N, Yi ES (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35:825–831.CrossRefPubMed Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, Weidner N, Yi ES (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35:825–831.CrossRefPubMed
16.
go back to reference Ranchod M, Levine GD (1980) Spindle-cell carcinoid tumors of the lung: a clinicopathologic study of 35 cases. Am J Surg Pathol 4:315–331.CrossRefPubMed Ranchod M, Levine GD (1980) Spindle-cell carcinoid tumors of the lung: a clinicopathologic study of 35 cases. Am J Surg Pathol 4:315–331.CrossRefPubMed
17.
go back to reference Tsuta K, Kalhor N, Wistuba II, Moran CA (2011) Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology 59:526–536.CrossRefPubMed Tsuta K, Kalhor N, Wistuba II, Moran CA (2011) Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology 59:526–536.CrossRefPubMed
18.
go back to reference Tsuta K, Raso MG, Kalhor N, Liu DC, Wistuba II, Moran CA (2011) Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung. Histopathology 58:276–285.CrossRefPubMed Tsuta K, Raso MG, Kalhor N, Liu DC, Wistuba II, Moran CA (2011) Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung. Histopathology 58:276–285.CrossRefPubMed
19.
go back to reference Miller RR, Muller NL (1995) Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 19:653–658.CrossRefPubMed Miller RR, Muller NL (1995) Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 19:653–658.CrossRefPubMed
20.
go back to reference Churg A, Warnock ML (1976) Pulmonary tumorlet. A form of peripheral carcinoid. Cancer 37:1469–1477.CrossRefPubMed Churg A, Warnock ML (1976) Pulmonary tumorlet. A form of peripheral carcinoid. Cancer 37:1469–1477.CrossRefPubMed
21.
go back to reference Barbareschi M, Frigo B, Mosca L, Carboni N, Arrigoni GP, Leonardi E, Wilander E, Siegal GP, Shiro BC (1990) Bronchial carcinoids with S-100 positive sustentacular cells. A comparative study with gastrointestinal carcinoids, pheochromocytomas and paragangliomas. Pathol Res Pract 186:212–222.CrossRefPubMed Barbareschi M, Frigo B, Mosca L, Carboni N, Arrigoni GP, Leonardi E, Wilander E, Siegal GP, Shiro BC (1990) Bronchial carcinoids with S-100 positive sustentacular cells. A comparative study with gastrointestinal carcinoids, pheochromocytomas and paragangliomas. Pathol Res Pract 186:212–222.CrossRefPubMed
22.
go back to reference Capella C, Gabrielli M, Polak JM, Buffa R, Solcia E, Bordi C (1979) Ultrastructural and histological study of 11 bronchial carcinoids. Evidence for different types. Virchows Arch A Pathol Anat Histol 381:313–329.CrossRefPubMed Capella C, Gabrielli M, Polak JM, Buffa R, Solcia E, Bordi C (1979) Ultrastructural and histological study of 11 bronchial carcinoids. Evidence for different types. Virchows Arch A Pathol Anat Histol 381:313–329.CrossRefPubMed
23.
go back to reference Min KW (2013): Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration. Ultrastruct Pathol 37:23–35.CrossRefPubMed Min KW (2013): Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration. Ultrastruct Pathol 37:23–35.CrossRefPubMed
24.
go back to reference Swarts DR, van Suylen RJ, den Bakker MA, van Oosterhout MF, Thunnissen FB, Volante M, Dingemans AM, Scheltinga MR, Bootsma GP, Pouwels HM, van den Borne BE, Ramaekers FC, Speel EJ (2014) Interobserver variability for the WHO classification of pulmonary carcinoids. Am J Surg Pathol 38:1429–1436.CrossRefPubMed Swarts DR, van Suylen RJ, den Bakker MA, van Oosterhout MF, Thunnissen FB, Volante M, Dingemans AM, Scheltinga MR, Bootsma GP, Pouwels HM, van den Borne BE, Ramaekers FC, Speel EJ (2014) Interobserver variability for the WHO classification of pulmonary carcinoids. Am J Surg Pathol 38:1429–1436.CrossRefPubMed
25.
go back to reference Papaxoinis G, Nonaka D, O'Brien C, Sanderson B, Krysiak P, Mansoor W (2017) Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours. Endocr Pathol 28:60–70.CrossRefPubMed Papaxoinis G, Nonaka D, O'Brien C, Sanderson B, Krysiak P, Mansoor W (2017) Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours. Endocr Pathol 28:60–70.CrossRefPubMed
26.
go back to reference Nonaka D, Papaxoinis G, Mansoor W (2016) Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors. Am J Surg Pathol 40:738–744.CrossRefPubMed Nonaka D, Papaxoinis G, Mansoor W (2016) Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors. Am J Surg Pathol 40:738–744.CrossRefPubMed
27.
go back to reference Gmelich JT, Bensch KG, Liebow AA (1967) Cells of Kultschitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest 17:88–98.PubMed Gmelich JT, Bensch KG, Liebow AA (1967) Cells of Kultschitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest 17:88–98.PubMed
28.
go back to reference Gillespie JJ, Luger AM, Callaway LA: Peripheral spindled carcinoid tumor: a review of its ultrastructure, differential diagnosis, and biologic behavior. Hum Pathol 10:601–606, 1979.CrossRefPubMed Gillespie JJ, Luger AM, Callaway LA: Peripheral spindled carcinoid tumor: a review of its ultrastructure, differential diagnosis, and biologic behavior. Hum Pathol 10:601–606, 1979.CrossRefPubMed
Metadata
Title
Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations
Authors
George Papaxoinis
Angela Lamarca
Anne Marie Quinn
Wasat Mansoor
Daisuke Nonaka
Publication date
01-09-2018
Publisher
Springer US
Published in
Endocrine Pathology / Issue 3/2018
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-018-9530-y

Other articles of this Issue 3/2018

Endocrine Pathology 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.